Prefilled Syringes Market, by Material (Glass, Plastic/Polymer), by Drug Type (Biologics, Vaccines, Insulin, Anticoagulants, Flush Saline Syringes and Others), by Design (Single-chamber, Dual-chamber, and Multi-chambered), by Product Type (Staked in-needle pre-filled syringes and Needle-free pre-filled syringes), by Usability (Disposable and Reusable), by Manufacturing Method (Captive and Merchant), by End User (Hospitals, Clinics, Ambulatory Surgical Centers and Others), by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Published In : Jun 2023

Code : CMI162

Pages :401

Formats :

Excel and PDF

Industry : Pharmaceutical

Market Challenges And Opportunities

Global Prefilled Syringes Market- Driver

Increasing Product Launches by Market Players

Major companies operating in the global prefilled syringes market are focused on organic growth strategies such as product launches, which is expected to drive growth of the global prefilled syringes market over the forecast period. For instance, in October 2022, Hikma Pharmaceuticals PLC., a pharmaceutical company, launched Succinylcholine Chloride Injection, in prefilled syringe (PFS) form. Succinylcholine Chloride is an important medicine used in hospitals for general anesthesia, to facilitate tracheal intubation, and to provide muscle relaxation during surgery or mechanical ventilation. The U.S. FDA-approved 100mg/5mL prefilled syringes for medication to introduced in the U.S.

Product Recalls

Several syringes have been recalled owing to defects in the container or plunger design, which makes the filling of drugs in them inefficient. The recent recalls of prefilled and pre-fillable syringes around the world are expected to significantly hamper the growth of the market over the forecast period.

For instance, in June 2022, Nephron Pharmaceuticals, a company that manufactures generic respiratory medications, issued a voluntary recall of some of its pre-filled syringe products due to concerns over the lack of assurance of sterility. The manufacturer indicated that the product recall was issued out of an abundance of caution and that there was no impact on patient safety.

To overcome the restraint, market players should focus on developing more safe and efficient devices adhering to all regulations and avoiding any contamination.

Availability of Alternate Drug Delivery Methods

Novel drug delivery systems involve creative formulations, new technology, and novel approaches for safely delivering pharmaceutical drugs into the body as needed to produce their intended pharmacological effects.

For instance, in 2021, Jabil Healthcare, a manufacturing services company, launched a new reusable autoinjector platform called Qfinity, a spring-driven, reusable device for use with a variety of drugs, including larger volume, higher viscosity medicines. The reusable injector operates with disposable cassettes in 1- and 2.25-ml sizes and a viscosity target of 30cP.

Market players should focus on strategies such as technology advancement of prefilled syringes, which would shift the customers to adopt prefilled syringes as the drug delivery methods instad of any alternatives, thus driving the market growth over forecast period